Ipca Laboratories Q2 PAT seen up 7.3% YoY to Rs 292.6 cr: Prabhudas Lilladher

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

live

• bselive
• nselive

Volume

Todays L/H

More

×

Prabhudas Lilladher has come out with its second quarter (July-September’ 21) earnings estimates for the Pharma sector. The brokerage house expects Ipca Laboratories to report net profit at Rs 292.6 crore up 7.3% year-on-year (up 2.8% quarter-on-quarter).

Net Sales are expected to increase by 10.7 percent Y-o-Y (down 2.8 percent Q-o-Q) to Rs 1,437.2 crore, according to Prabhudas Lilladher.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 7.7 percent Y-o-Y (down 1.5 percent Q-o-Q) to Rs 388 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More